Angela Ragone - Publications

Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 monoclonal antibodies: a systematic review and meta-analysis of observational studies.

Journal: Expert opinion on drug safety

Published: October 13, 2025

Monocyte distribution width in breast cancer: Results from a retrospective exploratory pilot study.

Journal: Molecular and clinical oncology

Published: August 21, 2025

Uncovering prognostic biomarkers through a pharmacovigilance study: the case of RDW.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 13, 2025

Unravelling the Adiponectin Hallmark and Exploring the Therapeutic Potential of Its Receptor Agonists in Cancer Metabolic Reprogramming.

Journal: Biomolecules

Published: April 30, 2025

Combining AdipoRon with Paclitaxel Unveils Synergistic Potential in Non-Small Cell Lung Cancer Cells via AMPK-ERK1/2 Signaling.

Journal: Cells

Published: March 04, 2025

Adiponectin Receptor Agonist AdipoRon Inhibits Proliferation and Drives Glycolytic Dependence in Non-Small-Cell Lung Cancer Cells.

Journal: Cancers

Published: June 13, 2024

Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis.

Journal: World journal of gastroenterology

Published: December 11, 2023

Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.

Journal: Cancers

Published: August 01, 2023

A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells.

Journal: International journal of molecular sciences

Published: November 18, 2022

Forskolin affects proliferation, migration and Paclitaxel-mediated cytotoxicity in non-small-cell lung cancer cell lines via adenylyl cyclase/cAMP axis.

Journal: European journal of cell biology

Published: October 14, 2022

AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: March 07, 2022

Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines.

Journal: Frontiers in pharmacology

Published: December 16, 2021